Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01946100 · ClinicalTrials.gov registry record · NA
Treatment of Multifocal Lung Adenocarcinoma
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT01946100: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT01946100 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01946100, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
To gather preliminary safety and outcome data for the multimodality treatment of lung adenocarcinoma in the setting of multifocal BAC.
Interventions
- GENETIC Multifocal Lung Adenocarcinoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2013-11-06 |
| Est. Completion | 2025-05-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01946100
The ClinicalTrials.gov registry entry for NCT01946100 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Multifocal Lung Adenocarcinoma is the first listed.
NCT01946100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01946100 about?
NCT01946100 is a clinical study titled "Treatment of Multifocal Lung Adenocarcinoma". To gather preliminary safety and outcome data for the multimodality treatment of lung adenocarcinoma in the setting of multifocal BAC.
What is the current status of trial NCT01946100?
This trial is currently terminated. It is a NA study. The enrollment target is 100 participants. The study started on 2013-11-06. Estimated completion is 2025-05-29.
What interventions are being tested in trial NCT01946100?
The interventions under investigation include: Multifocal Lung Adenocarcinoma (GENETIC).
Who is sponsoring clinical trial NCT01946100?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.